Table 2.
Infection | Infection Na | Cancer N (%) | Hazard ratio (95% CI)b | p value |
---|---|---|---|---|
No selected infectionc | 364,324 | 258 (0.07) | 1.00 | |
Any selected infectionc | 107,426 | 62 (0.06) | 1.23 (0.92–1.64) | 0.168 |
Esophageal candidiasis | 42,216 | 28 (0.07) | 1.34 (0.90–1.98) | 0.147 |
Mycobacterium avium complex | 22,351 | 6 (0.03) | 0.77 (0.29–2.07) | 0.603 |
Mucocutaneous herpes | 14,351 | 15 (0.10) | 1.69 (0.97–2.95) | 0.066 |
Cytomegalovirus, systemic | 14,127 | 5 (0.04) | 1.03 (0.42–2.49) | 0.952 |
Cryptococcosis, extrapulmonary | 13,884 | 4 (0.03) | 0.74 (0.27–1.98) | 0.542 |
Extrapulmonary tuberculosis | 8,737 | 7 (0.08) | 1.60 (0.75–3.40) | 0.222 |
Cryptosporidiosis | 7,978 | 7 (0.09) | 2.08 (0.93–4.70) | 0.077 |
Atypical mycobacterium | 4,633 | 2 (0.04) | 1.03 (0.26–4.15) | 0.965 |
Salmonella septicemia | 933 | 1 (0.11) | 2.10 (0.29–14.96) | 0.461 |
Coccidioidomycosis | 587 | 0 (0.00) | — | 0.958 |
Pneumocystis pneumonia | 117,373 | 48 (0.04) | 0.79 (0.57–1.10) | 0.167 |
Cancers occurred within risk period of 4 to 120 months after AIDS diagnosis.
Infections are not mutually exclusive.
Models were run separately for each condition and adjusted for age, sex, race, mode of HIV acquisition, CD4 count, and AIDS diagnosis year.
Selected infections are listed as those that may involve the colorectum, excluding pneumocystis pneumonia.